
Spring 2026
By Hannah White Hannah
Dana-Farber Cancer Institute’s Mohammad Rashidian, PhD, received a $250,000 Translational Research Award from the International Myeloma Society and the Paula and Rodger Riney Foundation. This support will advance his innovative work to combat disease relapse in multiple myeloma patients following CAR T-cell therapy.
